kresmion.
Pull a receipt

Apellis Pharmaceuticals, Inc. (APLS.D)

No longer listed. Deregistered with the SEC on 2026-05-14; it traded as APLS. Its history below is kept as recorded. All companies no longer listed
Sector
Biotechnology
Last price
$41.03
As of

Kresmion compiles this page from APLS.D's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Apellis Pharmaceuticals, Inc. (APLS.D): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-05-14.

As of . Source: SEC EDGAR filings for APLS.D. Method and limitations.

COMPANY DOSSIER

See the full APLS.D dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for APLS.D on one page. Preview it with sample data, then open it live with a free account.

Preview the APLS.D dossier

Active events for APLS.D

No recent events on APLS.D in the last 180 days.

FREE, NO ACCOUNT

Every event on APLS.D, as it fires

New filings, 13F moves and cross asset events on APLS.D land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.

Recent SEC filings, APLS.D

More data on APLS.D

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in APLS.D on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on APLS.D in the last 180 days.

Upstream: SEC EDGAR filings for APLS.D

Kresmion, "Apellis Pharmaceuticals, Inc. (APLS.D) institutional holdings and SEC filings", data as of 2026-05-14, https://kresmion.com/research/APLS.D. Upstream data: SEC EDGAR filings for APLS.D.

Link to this data (HTML):

<a href="https://kresmion.com/research/APLS.D">Apellis Pharmaceuticals, Inc. (APLS.D) institutional holdings and SEC filings (Kresmion)</a>

Follow APLS.D on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to APLS.D for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the APLS.D dossier
Share

The APLS.D intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.